| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |